Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
Barlogie B, Tricot GJ, van Rhee F, Angtuaco E, Walker R, Epstein J, Shaughnessy JD, Jagannath S, Bolejack V, Gurley J, Hoering A, Vesole D, Desikan R, Siegel D, Mehta J, Singhal S, Munshi NC, Dhodapkar M, Jenkins B, Attal M, Harousseau JL, Crowley J. Barlogie B, et al. Among authors: bolejack v. Br J Haematol. 2006 Oct;135(2):158-64. doi: 10.1111/j.1365-2141.2006.06271.x. Epub 2006 Aug 25. Br J Haematol. 2006. PMID: 16939489 Free article. Clinical Trial.
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
Pineda-Roman M, Bolejack V, Arzoumanian V, Anaissie E, van Rhee F, Zangari M, Walker R, Hollmig K, Shaughnessy JD Jr, Epstein J, Krishna S, Crowley J, Barlogie B. Pineda-Roman M, et al. Among authors: bolejack v. Br J Haematol. 2007 Feb;136(3):393-9. doi: 10.1111/j.1365-2141.2006.06441.x. Epub 2006 Dec 8. Br J Haematol. 2007. PMID: 17156398 Free article. Clinical Trial.
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
Barlogie B, Anaissie E, van Rhee F, Haessler J, Hollmig K, Pineda-Roman M, Cottler-Fox M, Mohiuddin A, Alsayed Y, Tricot G, Bolejack V, Zangari M, Epstein J, Petty N, Steward D, Jenkins B, Gurley J, Sullivan E, Crowley J, Shaughnessy JD Jr. Barlogie B, et al. Among authors: bolejack v. Br J Haematol. 2007 Jul;138(2):176-85. doi: 10.1111/j.1365-2141.2007.06639.x. Br J Haematol. 2007. PMID: 17593024 Free article. Clinical Trial.
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).
Hussein MA, Bolejack V, Zonder JA, Durie BG, Jakubowiak AJ, Crowley JJ, Barlogie B. Hussein MA, et al. Among authors: bolejack v. J Clin Oncol. 2009 Jul 20;27(21):3510-7. doi: 10.1200/JCO.2008.19.9240. Epub 2009 Jun 22. J Clin Oncol. 2009. PMID: 19546405 Free PMC article. Clinical Trial.
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
van Rhee F, Bolejack V, Hollmig K, Pineda-Roman M, Anaissie E, Epstein J, Shaughnessy JD Jr, Zangari M, Tricot G, Mohiuddin A, Alsayed Y, Woods G, Crowley J, Barlogie B. van Rhee F, et al. Among authors: bolejack v. Blood. 2007 Aug 1;110(3):827-32. doi: 10.1182/blood-2007-01-067728. Epub 2007 Apr 6. Blood. 2007. PMID: 17416735 Free PMC article. Clinical Trial.
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Ludwig H, Durie BG, Bolejack V, Turesson I, Kyle RA, Blade J, Fonseca R, Dimopoulos M, Shimizu K, San Miguel J, Westin J, Harousseau JL, Beksac M, Boccadoro M, Palumbo A, Barlogie B, Shustik C, Cavo M, Greipp PR, Joshua D, Attal M, Sonneveld P, Crowley J. Ludwig H, et al. Among authors: bolejack v. Blood. 2008 Apr 15;111(8):4039-47. doi: 10.1182/blood-2007-03-081018. Epub 2008 Feb 11. Blood. 2008. PMID: 18268097 Free PMC article.
71 results